Mesohyal Argibenone 5x3ml

Mesohyal Argibenone 5x3ml

A solution with anti-aging and antioxidant properties that combines the action of a biomimetic peptide (hexapeptide), which inhibits the exocytosis of acetylcholine, relaxing micro-contractions, and reduces facial wrinkles.

Indications

• Anti-aging effect, facial wrinkles on the forehead, around the eyes, nasolabial folds,
• Reduction of signs and prevention of photoaging.

Active ingredients

• Acetyl Hexapeptide-8 - Prevents muscle contractions, causing their reversible relaxation, and inhibits the formation of wrinkles,
• Idebenone - Antioxidant effect, collagen protection during sun exposure (MMP).
• Sodium hyaluronate 15 mg/ml - Stimulation of collagen synthesis and hydration.

Action

Peptides act as regulators of cellular biochemical mechanisms through the interaction of their specific amino acid sequence with receptors or endogenous molecules.

Perfectly regenerates the skin around the eyes and lips.

The preparation can be used as an anti-aging treatment.

A full treatment session prevents the formation of new wrinkles and reduces existing ones.

Application sites

• Face, neck, cleavage

5 sessions with an interval of 15 days between treatments

Durability of effects

• It depends on the patient's individual predispositions - up to about 9 months.

Pass

Evaluation of the effectiveness and safety of intradermal administration of mesohyal™ ARGIBENONE in the treatment of wrinkles and facial expression lines.

• Administration per treatment: 1 vial
• Volume per administration point: 0.02 ml to 0.05 ml
• Depth: from 0.5 mm to 4 mm depending on the treated facial surface
• Passing technique: point by point. 3-body syringe with Luer-Lock technology, 3 ml, with a 13 mm needle, 30 g capacity
• Application area: face and eye area

INCI

Hexapeptide (ERM) 2 (acetyl hexapeptide-8) Idebenone, Sodium hyaluronate 15 mg/ml.
POSSIBLE SIDE EFFECTS

Before starting treatment, the patient must be informed about the indications for use
product, precautions, contraindications, incompatibilities, as well as possible side effects that may occur when using mesohyal ARGIBENONE, immediately after the procedure or some time later.

These possible side effects include: injection-related reactions that may last up to a week, such as inflammation, slight swelling, erythema, swelling, pain, itching and/or bruising at the injection site; lumps or hardness at the injection site.

Adverse effects persisting for more than one week or the occurrence of any other adverse reactions should be reported immediately to the responsible physician, who should administer appropriate treatment.

Any other types of adverse reactions should be reported directly to the manufacturer of mesohyal ARGIBENONE.

CONTRAINDICATIONS

- The preparation should never be injected into the bloodstream.
- Use on intact skin, do not use in case of irritation, erythema, inflammation, wounds or burns.
- The preparation cannot be used by: patients with any skin disease or condition
with a history of autoimmune diseases or treated with immunosuppressive drugs or immunotherapy, patients with a history of or hypersensitivity to salicylic acid or some of its derivatives, patients with hypersensitivity or known allergy to any of the ingredients of the preparation, pregnant or breastfeeding women.

Patients with acne and/or other active inflammatory diseases.

The product is intended for use by a professional.